Iradimed (IRMD) Total Current Liabilities (2013 - 2026)

Iradimed (IRMD) has 14 years of Total Current Liabilities data on file, last reported at $12.1 million in Q1 2026.

• On a quarterly basis, Total Current Liabilities rose 43.01% year-over-year to $12.1 million in Q1 2026; TTM through Mar 2026 was $12.1 million, a 43.01% increase from a year earlier, with the FY2025 full-year figure at $10.2 million, up 19.6% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $12.1 million, up from $10.2 million in the prior quarter.
• Over the last five years, Total Current Liabilities for IRMD reached as high as $16.3 million in Q4 2023 and fell as low as $5.6 million in Q3 2022.
• Historically, Total Current Liabilities has averaged $8.8 million across 5 years, with a median of $8.1 million in 2024.
• Across the five-year window, Total Current Liabilities surged 90.88% in 2023 and plunged 47.87% in 2024, its largest moves.
• Year by year, Total Current Liabilities stood at $8.6 million in 2022, then soared by 90.88% to $16.3 million in 2023, then tumbled by 47.87% to $8.5 million in 2024, then gained by 19.6% to $10.2 million in 2025, then gained by 19.04% to $12.1 million in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $12.1 million in Q1 2026, $10.2 million in Q4 2025, and $12.8 million in Q3 2025.